|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| G01N 33/567 | (2006.01) | ||
| C07K 16/24 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2548577 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12174197.9 |
| Date of filing the European patent application | 2006-12-28 | |
| (97) | Date of publication of the European application | 2013-01-23 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-15 |
| (46) | Date of publication of the claims translation | 2017-04-10 |
| (30) | Number | Date | Country code |
| 754889 P | 2005-12-29 | US |
| (72) |
Benson, Jacqueline, US
Carton, Jill, US
Cunningham, Mark, US
Orlovsky, Yevgeniya I., US
Rauchenberger, Robert, DE
Sweet, Raymond, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Žmogaus anti-IL-23 antikūnai, kompozicijos, būdai ir panaudojimai |
| HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES |
| Payment date | Validity (years) | Amount | |
| 2024-11-25 | 19 | 347.00 EUR |
| 2025-12-28 |